The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118108264 11810826 4 F 20151123 20160826 20151208 20160901 EXP GB-ROCHE-1669244 ROCHE 64.18 YR F Y 0.00000 20160901 MD GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118108264 11810826 1 PS Pertuzumab PERTUZUMAB 1 Intravenous (not otherwise specified) LOADING DOSE 125409 840 MG SOLUTION FOR INFUSION QD
118108264 11810826 2 SS Pertuzumab PERTUZUMAB 1 Intravenous (not otherwise specified) MAINTAINANCE DOSE. 125409 420 MG SOLUTION FOR INFUSION Q3W
118108264 11810826 3 SS Trastuzumab TRASTUZUMAB 1 Intravenous (not otherwise specified) LOADING DOSE 103792 525 MG SOLUTION FOR INFUSION QD
118108264 11810826 4 SS Trastuzumab TRASTUZUMAB 1 Intravenous (not otherwise specified) MAINTAINANCE DOSE. 103792 399 MG SOLUTION FOR INFUSION Q3W
118108264 11810826 5 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) 0 130 MG QD
118108264 11810826 6 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) 0 80 MG QD
118108264 11810826 7 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) 0 90 MG Q3W
118108264 11810826 8 C TAZOCIN PIPERACILLIN SODIUMTAZOBACTAM SODIUM 1 Intravenous (not otherwise specified) 0 4.5 MG TID
118108264 11810826 9 C AMOXYCILLIN AMOXICILLIN 1 Oral 0 TABLET
118108264 11810826 10 C AMOXYCILLIN AMOXICILLIN 1 Unknown 0
118108264 11810826 11 C FLUCLOXACILLIN FLUCLOXACILLIN 1 Oral 0
118108264 11810826 12 C RIVAROXABAN RIVAROXABAN 1 Oral 0 15 MG TABLET BID
118108264 11810826 13 C RIVAROXABAN RIVAROXABAN 1 Oral 0 TABLET QD
118108264 11810826 14 C FLUCONAZOLE. FLUCONAZOLE 1 Oral 0 TABLET
118108264 11810826 15 C STREPTOKINASE STREPTOKINASE 1 Intravenous (not otherwise specified) 250000 0
118108264 11810826 16 C DALTEPARIN DALTEPARIN 1 Subcutaneous 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118108264 11810826 1 Breast cancer metastatic
118108264 11810826 3 Breast cancer metastatic
118108264 11810826 5 Breast cancer metastatic
118108264 11810826 8 Pyrexia
118108264 11810826 9 Cellulitis
118108264 11810826 11 Cellulitis
118108264 11810826 12 Pyrexia

Outcome of event

Event ID CASEID OUTC COD
118108264 11810826 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
118108264 11810826 Nausea
118108264 11810826 Productive cough
118108264 11810826 Sepsis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118108264 11810826 1 20150520 20150520 0
118108264 11810826 2 20150622 0
118108264 11810826 3 20150521 20150521 0
118108264 11810826 4 20150622 0
118108264 11810826 5 20150522 20150522 0
118108264 11810826 6 20150622 20150622 0
118108264 11810826 7 20150714 20150915 0
118108264 11810826 8 20151005 20151012 0
118108264 11810826 9 20150929 0
118108264 11810826 10 20160122 0
118108264 11810826 11 20150929 0
118108264 11810826 12 20151014 20151103 0
118108264 11810826 13 20151104 0
118108264 11810826 14 20160122 0
118108264 11810826 15 20151005 20151014 0
118108264 11810826 16 20151005 20151014 0